Endowment Wealth Management, Inc. - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 76 filers reported holding HUMACYTE INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
Endowment Wealth Management, Inc. ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$285,728
-10.6%
97,5180.0%0.26%
-12.3%
Q2 2023$319,481
+7.0%
97,518
+0.9%
0.29%
-2.3%
Q1 2023$298,550
+46.4%
96,6180.0%0.30%
+33.9%
Q4 2022$203,864
-35.3%
96,6180.0%0.22%
-41.4%
Q3 2022$315,000
+1.6%
96,6180.0%0.38%
+2.4%
Q2 2022$310,000
-54.5%
96,6180.0%0.37%
-48.0%
Q1 2022$682,000
-2.6%
96,6180.0%0.72%
+1.3%
Q4 2021$700,00096,6180.71%
Other shareholders
HUMACYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders